Peer-reviewedCC BY-NC-NDInfectious diseases & immunity
Bepirovirsen improves the functional cure of chronic hepatitis B through novel mechanisms.
- 1Department of Infectious Diseases and Hepatology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
- 2Senior Department of Infectious Diseases, Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, China.
Related
- 만성 B형간염에서 Bepirovirsen 3상 임상시험: 기간 한정 치료를 통한 기능적 완치의 가능성 Phase 3 Trials of Bepirovirsen in Chronic Hepatitis B: Toward Functional Cure with Finite Therapy
- Established Versus Novel Strategies for Hepatitis B Functional Cure: A Cross-Regional Cost-Effectiveness Analysis of Pegylated Interferon and Bepirovirsen Add-on Therapy
- Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection
- Value-based price corridor for bepirovirsen in chronic hepatitis B: an early health technology assessment in a cost-compressed setting.
- High Frequency of Circulating IL-4R+SELL+ Naïve B Cells Is Associated with Functional Cure in Chronic Hepatitis B Patients Receiving Antiviral Treatment
BibTeX
@article{zeng2026bepirovirsen,
title = {{Bepirovirsen improves the functional cure of chronic hepatitis B through novel mechanisms.}},
author = {Qing-Lei Zeng and Junliang Fu},
journal = {Infectious diseases \& immunity},
year = {2026},
month = aug,
doi = {10.1097/id9.0000000000000220},
url = {https://europepmc.org/article/MED/42904255},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Bepirovirsen improves the functional cure of chronic hepatitis B through novel mechanisms.
AU - Qing-Lei Zeng
AU - Junliang Fu
PY - 2026
DA - 2026/08/07
JO - Infectious diseases & immunity
DO - 10.1097/id9.0000000000000220
UR - https://europepmc.org/article/MED/42904255
SN - 2096-9511
SN - 2693-8839
ER -